Placental-Derived Stem Cells: Potential Clinical Applications

作者: Sean Murphy , Euan Wallace , Graham Jenkin

DOI: 10.1007/978-1-60761-860-7_15

关键词:

摘要: Placental-derived stem cells are easily accessible and do not have many of the limitations embryonic their derivatives for use in clinical trials. Preclinical animal studies using amnion and, more recently, human epithelial (hAECs) provided evidence exciting potential applications. We characterized hAECs derived from term gestational tissues investigated application treatment adult perinatal lung injury. Studies by our group shown that display key features pluripotent cells. They form teratomas after transplantation into testes immunodeficient mice, they restricted expression major histocompatibility antigens vitro. also appear to suppress lymphocyte proliferation. Collectively, these findings indicate may elicit minimal immune recognition following an allogeneic recipient native form. Our observations on reparative effects models injury encouraged us investigate as a cellular therapy bronchopulmonary dysplasia respiratory distress syndrome preterm infants. In utero ventilation model fetal sheep, preliminary results administration reduces inflammation fibrosis, thus providing novel very infant. research multipotential amnion-derived well revolutionize approach therapies.

参考文章(106)
John D. Trelford, Marilyn Trelford-Sauder, The amnion in surgery, past and present. American Journal of Obstetrics and Gynecology. ,vol. 134, pp. 833- 845 ,(1979) , 10.1016/0002-9378(79)90957-8
Vladimir Serikov, Catherine Hounshell, Sandra Larkin, William Green, Hirokazu Ikeda, Mark C. Walters, Frans A. Kuypers, Human term placenta as a source of hematopoietic cells. Experimental Biology and Medicine. ,vol. 234, pp. 813- 823 ,(2009) , 10.3181/0809-BC-262
Maureen Owen, A. J. Friedenstein, Stromal Stem Cells: Marrow‐Derived Osteogenic Precursors Ciba Foundation Symposium. ,vol. 136, pp. 42- 60 ,(1988) , 10.1002/9780470513637.CH4
Francesco Alviano, Valentina Fossati, Cosetta Marchionni, Mario Arpinati, Laura Bonsi, Michele Franchina, Giacomo Lanzoni, Silvia Cantoni, Claudia Cavallini, Francesca Bianchi, Pier Tazzari, Gianandrea Pasquinelli, Laura Foroni, Carlo Ventura, Alberto Grossi, Gian Bagnara, Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro BMC Developmental Biology. ,vol. 7, pp. 11- 11 ,(2007) , 10.1186/1471-213X-7-11
J M Houlihan, C H Holmes, H M Harper, P A Biro, H J Jenkinson, The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. Journal of Immunology. ,vol. 154, pp. 5665- 5674 ,(1995)
Sean Murphy, Sharina Rosli, Rutu Acharya, Louisa Mathias, Rebecca Lim, Euan Wallace, Graham Jenkin, Amnion epithelial cell isolation and characterization for clinical use. Current protocols in stem cell biology. ,vol. 13, pp. 0- 0 ,(2010) , 10.1002/9780470151808.SC01E06S13
Sonia C Picinich, Pravin J Mishra, Prasun J Mishra, John Glod, Debabrata Banerjee, The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opinion on Biological Therapy. ,vol. 7, pp. 965- 973 ,(2007) , 10.1517/14712598.7.7.965
M Feess, J S Hunt, G W Wood, G K Andrews, J L Fishback, Amnion membrane epithelial cells express class I HLA and contain class I HLA mRNA. Journal of Immunology. ,vol. 140, pp. 2790- 2795 ,(1988)
Yasushi Sonoda, Masahiko Usui, Ryuji Muramatsu, Masato Kubo, Immunogenicity of human amniotic membrane in experimental xenotransplantation Investigative Ophthalmology & Visual Science. ,vol. 42, pp. 1539- 1546 ,(2001)